GLP-1 receptor agonists, such as Wegovy, Ozempic, and Mounjaro, have been grabbing headlines since 2021 when they were first approved in the United States for weight loss. Their growth has outpaced all expectations, with seemingly everyone knowing someone—family, friends, neighbors, or coworkers—who have used or is using one of these medications.

Elizabeth Briand

Underserved populations face numerous barriers with CGM access, including poor digital health literacy. However, pharmacists can help patients overcome these roadblocks, according to a commentary published in the March/April 2026 issue of JAPhA.

Natalie Fritzson

“One story I will never forget is a man standing in front of me crying because we were able to secure a grant to cover his copays,” said Angela Walters, RPh. “The man said, ‘You just saved my house for me.’ ”

Lauren Howell, PharmD

Ten years have passed since SB 5557 was signed into law, making pharmacists in Washington state providers in private health plans.

Loren Bonner

At least 25% of seasoned pharmacy leaders will leave their positions earlier than expected, according to ASHP’s 2023 Pharmacy Forecast. This turnover, coupled with the already growing demand for pharmacy leaders, highlights the importance of younger pharmacists learning from those in leadership positions.

Lauren Howell, PharmD

Community pharmacies are public places where private conversations are held.

David B. Brushwood, BSPharm, JD

ISMP has previously noted the potential confusion between Danziten (nilotinib tartrate) and Tasigna (nilotinib hydrochloride).

Institute for Safe Medication Practices, Horsham, PA

Updates from FDA

APhA Staff

Milk thistle supplements are among the top-selling botanicals sold as a natural way to support liver health and even as a pre-party and post-celebration liver detox. With such a big promise for a little weed, does this herb deliver?

Mickie Cathers

Authors of a review paper published in the January 2026 issue of JAMA Psychiatry call for a needed shift in research efforts on psilocybin—a Schedule I substance—from controlled clinical trials to exploring public health consequences.

Kevin Willmann

Even though there has been a significant global rise in melatonin prescriptions for young children, findings are limited on its effectiveness in those with typical development, a study published in JAMA on January 2, 2026, suggests.

Loren Bonner

A long-standing rule in thyroid care may be more flexible than once thought. Research published in the April 2026 issue of the Journal of Clinical Endocrinology & Metabolism suggests that patients taking levothyroxine for hypothyroidism may not need to take the medication on an empty stomach.

Sonya Collins

The American Diabetes Association (ADA) released Supplement 1 to the January issue of Diabetes Care with updates to its Standards of Care in Diabetes early this year. A central theme of the updated section, “Improving Care and Promoting Health in Populations,” is that better outcomes will depend on system-level change.

Sonya Collins

When it comes to OTC cold medications, there is an abundance of options from which patients can choose. But, navigating those many options in the cold medicine aisle to treat a runny nose, cough, and sore throat can be overwhelming.

Lauren Howell, PharmD

Hydralazine, a rapid, direct-acting vasodilator first introduced in the 1950s, is still routinely prescribed for cardiovascular conditions or for treating hypertension in hypertensive emergencies.

APhA Staff

Despite explicit FDA guidance against its use in females of childbearing potential, approximately 1 in 5 valproic acid (VPA) prescriptions in the United States between 2017 and 2022 were dispensed to this population.

Aiya Almogaber, PharmD

Community-acquired pneumonia remains a leading cause of hospitalization, yet clinicians still struggle to distinguish viral from bacterial etiologies.

Corey Diamond, PharmD

When acute allergic reactions happen in schools, workplaces, and restaurants, patients must quickly evaluate their symptoms and decide whether to administer epinephrine.

Jen Hand

Pharmacists are emerging as a critical, and increasingly recognized, solution to one of health care’s most persistent problems: uncontrolled hypertension.

Sonya Collins

Christopher R. Piszczatoski, PharmD, BCPSChristopher R. Piszczatoski, PharmD, BCPSIn recent years, GLP-1 receptor agonists have exploded in popularity and usage.

Christopher R. Piszczatoski, PharmD, BCPSChristopher R. Piszczatoski, PharmD, BCPS

APhA Member News

APhA staff

Take the Crossword Challenge